NPI: 1366486102 · PROVIDENCE, RI 02903 · 2084N0400X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,152 | $1.71M |
| 2019 | 1,202 | $41K |
| 2020 | 870 | $118K |
| 2021 | 1,219 | $298K |
| 2022 | 1,838 | $1.06M |
| 2023 | 3,478 | $4.73M |
| 2024 | 1,963 | $1.92M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J2323 | Natalizumab injection | 802 | 540 | $5.01M |
| J2350 | Injection, ocrelizumab, 1 mg | 148 | 132 | $3.90M |
| 96413 | 1,535 | 729 | $331K | |
| 99214 | 4,158 | 3,990 | $248K | |
| 96415 | 214 | 193 | $121K | |
| 96367 | 137 | 120 | $71K | |
| 96365 | 572 | 526 | $59K | |
| J1100 | Dexamethasone sodium phos | 73 | 64 | $41K |
| 99215 | Prolong outpt/office vis | 225 | 208 | $21K |
| 99205 | Prolong outpt/office vis | 108 | 105 | $19K |
| 93042 | 4,175 | 3,131 | $18K | |
| 95951 | 28 | 13 | $9K | |
| 95816 | 218 | 209 | $8K | |
| 95720 | 66 | 39 | $5K | |
| 99204 | 31 | 31 | $4K | |
| 99213 | 63 | 63 | $4K | |
| 64615 | 12 | 12 | $1K | |
| 95819 | 27 | 26 | $785.08 | |
| 93880 | 12 | 12 | $422.79 | |
| 95886 | 13 | 13 | $218.70 | |
| 95885 | 14 | 14 | $165.56 | |
| 93040 | 12 | 12 | $125.84 | |
| 99443 | 79 | 79 | $0.00 |